Nuvalent, Inc.
NUVL
50 insider filings · Latest: Jul 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2025 | Sep 10 8:38 PM | HENRY E PELISH | Proposed Sale | 6,158 | $78.73 | $484.8K | — | View → |
| Jul 24, 2025 | Jul 25 12:42 AM | BCLS II INVESTCO, LP | Proposed Sale | 4,253 | $82.08 | $349.1K | — | View → |
| Jul 24, 2025 | Jul 25 12:35 AM | BCIP Life Sciences Associates, LP | Proposed Sale | 156,670 | $82.08 | $12.9M | — | View → |
| Jul 24, 2025 | Jul 25 12:31 AM | Bain Capital Life Sciences Fund II, L.P. | Proposed Sale | 1,286,344 | $82.08 | $105.6M | — | View → |
| Jul 15, 2025 | Jul 15 8:01 PM | James Richard Porter | Proposed Sale | 81,000 | $84.59 | $6.9M | — | View → |
| Jul 9, 2025 | Jul 9 10:06 PM | Henry E. Pelish | Proposed Sale | 2,145 | $81.15 | $174.1K | — | View → |
| Jun 27, 2025 | Jun 27 8:18 PM | Alexandra Balcom | Proposed Sale | 129,480 | $80.00 | $10.4M | — | View → |
| Jun 26, 2025 | Jun 26 8:03 PM | Darlene Noci | Proposed Sale | 12,000 | $79.07 | $948.8K | — | View → |
| Jun 6, 2025 | Jun 6 8:24 PM | HENRY E PELISH | Proposed Sale | 22,000 | $78.09 | $1.7M | — | View → |
| Apr 15, 2025 | Apr 15 8:15 PM | James Richard Porter | Proposed Sale | 81,000 | $70.00 | $5.7M | — | View → |
| Mar 6, 2025 | Mar 6 9:03 PM | Darlene Noci | Proposed Sale | 46,000 | $76.67 | $3.5M | — | View → |
| Jan 15, 2025 | Jan 15 10:10 PM | James Richard Porter | Proposed Sale | 81,000 | $72.39 | $5.9M | — | View → |
| Jan 6, 2025 | Jan 6 11:01 AM | Darlene Noci | Proposed Sale | 4,250 | $80.78 | $343.3K | — | View → |
| Jan 6, 2025 | Jan 6 11:01 AM | Henry E. Pelish | Proposed Sale | 2,750 | $80.78 | $222.1K | — | View → |
| Jan 6, 2025 | Jan 6 11:01 AM | Christopher Durant Turner | Proposed Sale | 4,250 | $80.78 | $343.3K | — | View → |
| Jan 6, 2025 | Jan 6 11:01 AM | Deborah Ann Miller | Proposed Sale | 3,250 | $80.78 | $262.5K | — | View → |
| Jan 6, 2025 | Jan 6 11:01 AM | Alexandra Balcom | Proposed Sale | 4,250 | $80.78 | $343.3K | — | View → |
| Jan 6, 2025 | Jan 6 11:01 AM | James Richard Porter | Proposed Sale | 18,000 | $80.78 | $1.5M | — | View → |
| Dec 11, 2024 | Dec 12 2:14 AM | BCIP Life Sciences Associates, LP | Proposed Sale | 135,714 | $93.61 | $12.7M | — | View → |
| Dec 11, 2024 | Dec 12 2:13 AM | Bain Capital Life Sciences Fund II, L.P. | Proposed Sale | 1,114,286 | $93.61 | $104.3M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Jun 10 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $18.93 | 148,686(D) | View → |
| Jun 1, 2026 | Jun 3 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $6.89 | 13,400(D) | View → |
| May 28, 2026 | Jun 1 8:31 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 86,829(D) | View → |
| May 28, 2026 | Jun 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 72,608(D) | View → |
| May 4, 2026 | May 6 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $18.93 | 178,686(D) | View → |
| May 1, 2026 | May 5 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $6.89 | 24,830(D) | View → |
| Apr 30, 2026 | May 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 78,108(D) | View → |
| Apr 29, 2026 | May 1 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 92,329(D) | View → |
| Apr 9, 2026 | Apr 13 8:30 PM | Henry E. PelishChief Scientific Officer | Option Exercise | 3,093 | $27.85 | 8,309(D) | View → |
| Apr 6, 2026 | Apr 8 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $27.85 | 131,494(D) | View → |
| Apr 1, 2026 | Apr 3 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $1.08 | 138,796(D) | View → |
| Apr 1, 2026 | Apr 2 8:30 PM | Benjamin LaneChief Technical Operations Officer | Grant/Award | 19,000 | $105.64 | 19,000(D) | View → |
| Mar 30, 2026 | Apr 1 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 97,829(D) | View → |
| Mar 26, 2026 | Mar 30 9:31 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 83,608(D) | View → |
| Mar 24, 2026 | Mar 26 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $1.08 | 150,226(D) | View → |
| Mar 12, 2026 | Mar 16 8:31 PM | Henry E. PelishChief Scientific Officer | Option Exercise | 17,320 | $72.35 | 21,073(D) | View → |
| Mar 6, 2026 | Mar 10 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $27.85 | 147,780(D) | View → |
| Feb 26, 2026 | Mar 2 9:34 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 103,329(D) | View → |
| Feb 26, 2026 | Mar 2 9:32 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 89,108(D) | View → |
| Jan 29, 2026 | Feb 2 9:30 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 108,829(D) | View → |